Circle Cardiovascular Imaging Partners with inHEART to Distribute AI-Driven Digital Twin of the Heart for Advanced Cardiac Procedural Planning in the Electrophysiology Lab

BOSTON, May 16, 2024 /PRNewswire/ -- Heart Rhythm Society (HRS) Conference -- Circle Cardiovascular Imaging Inc. and inHEART Inc. announced today a global distribution agreement enabling Circle to promote and market inHEART's advanced, AI-enabled digital twin of the heart through Circle's worldwide sales network. This partnership will allow inHEART to rapidly grow global commercialization of their procedural planning software solution to optimize image-guided cardiac ablations.

The inHEART solution creates highly detailed, interactive 3D heart models with proprietary AI-driven cardiac CT or MR image segmentation. These 3D models allow for interactive exploration of cardiac anatomy, principal and collateral structures, and myocardial tissue characteristics. This allows physicians to optimize treatment strategies based on each patient's unique cardiac anatomy and supports pre-procedural planning for faster ablation procedures and improved clinical outcomes. The inHEART system seamlessly integrates into all major electro-anatomical mapping (EAM) systems for use during ablation procedures.

Circle Cardiovascular Imaging (CVI) is known for its multi-modal AI-based solutions that streamline cardiac imaging and reporting workflows across the cardiac service line, including coronary artery disease, heart failure, and structural heart disease.  The Circle cvi42 platform offers easy-to-use, clinically validated tools that integrate seamlessly into existing clinical workflows to aid clinicians with quantification of cardiac function and flow, visualization of tissue abnormalities, automatic characterization and quantification of plaque within the coronary arteries, and pre-procedural planning through specialized workflows for TAVR/TMVR. Additionally, Circle's TruPlan software facilitates pre-procedural planning for left atrial appendage closure (LAAC) procedures. With the addition of inHEART's AI-driven cardiac models to optimize cardiac ablation procedures in the electrophysiology (EP) lab, this partnership empowers cardiovascular professionals with the tools and insights they need to deliver high-quality patient care while optimizing practice performance.